FI763050A - - Google Patents

Info

Publication number
FI763050A
FI763050A FI763050A FI763050A FI763050A FI 763050 A FI763050 A FI 763050A FI 763050 A FI763050 A FI 763050A FI 763050 A FI763050 A FI 763050A FI 763050 A FI763050 A FI 763050A
Authority
FI
Finland
Application number
FI763050A
Inventor
Alfred David Miller
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of FI763050A publication Critical patent/FI763050A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18Benzotriazoles
FI763050A 1975-10-28 1976-10-26 FI763050A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62614075A 1975-10-28 1975-10-28

Publications (1)

Publication Number Publication Date
FI763050A true FI763050A (fi) 1977-04-29

Family

ID=24509116

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763050A FI763050A (fi) 1975-10-28 1976-10-26

Country Status (12)

Country Link
JP (1) JPS5253863A (fi)
AU (1) AU1881176A (fi)
BE (1) BE847480A (fi)
DE (1) DE2648826A1 (fi)
DK (1) DK478176A (fi)
FI (1) FI763050A (fi)
FR (1) FR2329275A1 (fi)
IL (1) IL50699A0 (fi)
LU (1) LU76062A1 (fi)
NL (1) NL7611944A (fi)
NO (1) NO763569L (fi)
SE (1) SE7611884L (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI834666A (fi) * 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
CA2015267A1 (en) * 1989-05-26 1990-11-26 Rainer Seele 8-azolylmethylquinolines
ES2307925T3 (es) 2002-04-26 2008-12-01 Eli Lilly And Company Antagonistas de los receptores de la taquiquinina.
AU2003230829B8 (en) 2002-04-26 2008-12-11 Eli Lilly And Company Triazole derivatives as tachykinin receptor antagonists
WO2005000821A1 (en) * 2003-06-12 2005-01-06 Eli Lilly And Company Tachykinin receptor antagonists
MX2014009078A (es) 2012-01-26 2016-01-25 Vanda Pharmaceuticals Inc Tratamiento de trastornos del ritmo circadiano.
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
KR20170058464A (ko) 2012-12-18 2017-05-26 반다 파마슈티칼즈, 인코퍼레이티드. 일주기 리듬 장애의 치료
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
MX2017009824A (es) 2015-01-30 2017-11-02 Neurocrine Biosciences Inc Triazoles sustituidos y metodos relacionados a estos.
US9771335B2 (en) * 2015-07-31 2017-09-26 The Johns Hopkins University Derivatives of rufinamide and their use in inhibtion of the activation of human voltage-gated sodium channels
CN105801499A (zh) * 2016-04-15 2016-07-27 华东理工大学 烯酮制备新型有机oled试剂的设计及其应用
CN111196785B (zh) * 2020-01-21 2021-08-31 成都新朝阳作物科学股份有限公司 三氮唑衍生物及其制备方法和用途

Also Published As

Publication number Publication date
AU1881176A (en) 1978-04-27
JPS5253863A (en) 1977-04-30
SE7611884L (sv) 1977-04-29
BE847480A (fr) 1977-04-20
FR2329275A1 (fr) 1977-05-27
LU76062A1 (fi) 1977-05-18
IL50699A0 (en) 1976-12-31
DE2648826A1 (de) 1977-05-05
FR2329275B1 (fi) 1978-12-15
NL7611944A (nl) 1977-05-02
DK478176A (da) 1977-04-29
NO763569L (fi) 1977-04-29

Similar Documents

Publication Publication Date Title
JPS551809B2 (fi)
JPS553317B2 (fi)
JPS5193121A (fi)
FR2310972B3 (fi)
JPS51130580U (fi)
JPS5233666U (fi)
JPS5551090Y2 (fi)
JPS5351640Y2 (fi)
JPS5334B2 (fi)
JPS51150664U (fi)
JPS5282873U (fi)
JPS5225933U (fi)
JPS5215303U (fi)
CH597658A5 (fi)
CH602712A5 (fi)
BG22446A1 (fi)
CH606582A5 (fi)
CH605279A5 (fi)
CH604924A5 (fi)
CH604824A5 (fi)
BG23245A1 (fi)
CH604624A5 (fi)
CH604615A5 (fi)
BG26417A1 (fi)
CH597739A5 (fi)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: ICI UNITED STATES INC.